Development of dendritic cell loaded MAGE-A2 long peptide; a potential target for tumor-specific T cell-mediated prostate cancer immunotherapy
Cancer Cell International,
Abstract Background Prostate cancer (PCa) is the second leading cause of cancer-related deaths among men worldwide.